Financial Conflicts of Interest and Authorship of Clinical Practice Guidelines-Trust Is Fragile

被引：6
作者：
Mitchell, Philip B. [1 ]
机构：
[1] Univ New South Wales, Sch Psychiat, Sydney, NSW 2052, Australia
来源：
JAMA NETWORK OPEN | 2019年 / 2卷 / 04期
关键词：
D O I：
10.1001/jamanetworkopen.2019.2840
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 7 条
  • [1] Graham R, 2011, CLIN PRACTICE GUIDEL, DOI [10.17226/13058, DOI 10.17226/13058]
  • [2] Financial Conflicts of Interest Among Authors of Endocrine Society Clinical Practice Guidelines
    Irwig, Michael S.
    Kyinn, Mabel
    Shefa, Mason C.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (12) : 4333 - 4338
  • [3] Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry
    Mitchell, Philip B.
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2009, 191 (05) : 273 - 275
  • [4] Undisclosed financial ties between guideline writers and pharmaceutical companies: a cross-sectional study across 10 disease categories
    Moynihan, Ray
    Lai, Alexandra
    Jarvis, Huw
    Duggan, Geraint
    Goodrick, Stephanie
    Beller, Elaine
    Bero, Lisa
    [J]. BMJ OPEN, 2019, 9 (02):
  • [5] Beyond Moral Outrage - Weighing the Trade-Offs of COI Regulation
    Rosenbaum, Lisa
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (21) : 2064 - 2068
  • [6] Evaluation of Pharmaceutical Company Payments and Conflict of Interest Disclosures Among Oncology Clinical Practice Guideline Authors in Japan
    Saito, Hiroaki
    Ozaki, Akihiko
    Sawano, Toyoaki
    Shimada, Yuki
    Tanimoto, Tetsuya
    [J]. JAMA NETWORK OPEN, 2019, 2 (04) : e192834
  • [7] Author Financial Conflicts of Interest, Industry Funding, and Clinical Practice Guidelines for Anticancer Drugs
    Tibau, Ariadna
    Bedard, Philippe L.
    Srikanthan, Amirrtha
    Ethier, Josee-Lyne
    Vera-Badillo, Francisco E.
    Templeton, Arnoud J.
    Ocana, Alberto
    Seruga, Bostjan
    Barnadas, Agusti
    Amir, Eitan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (01) : 100 - U158
1